Login / Signup

Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.

Jung Min ChoJisuk ChaeSa Rang JeongMin Jung MoonDong Yeob ShinJong Ho Lee
Published in: PloS one (2020)
[NCT03677921]; www.clinicaltrials.gov [KCT0002726]; https://cris.nih.go.kr.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase ii
  • phase iii
  • endothelial cells
  • study protocol
  • phase ii study
  • open label
  • induced pluripotent stem cells
  • randomized controlled trial
  • squamous cell carcinoma